ALXO

NASDAQStock

ALX Oncology Holdings Inc.

$1.97-0.06 (-2.72%)

52-Week Range

$0.41

$2.60

Key Stats

Market Cap

106.6M

P/E Ratio

—

Dividend Yield

—

Beta

0.50

Volume

309.8K

Avg Volume

694.2K

Performance

-8.60%

+44.29%

+87.04%

YTD

+75.65%

+157.78%

-59.60%

-97.43%

Price Chart

ETF Exposure

ALXO is held by 12 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
CNCR	Loncar Cancer Immunotherapy ETF	3.21%	25,591	$861K	$12.7M	0.79%
FSMO	Fidelity Small-Mid Cap Opportunities ETF	0.01%	0	$2K	$742.2M	0.43%
VHT	Vanguard Health Care ETF	0.00%	77,209	$134K	$19.80B	0.09%
VXF	Vanguard Extended Market ETF	0.00%	352,104	$613K	$84.10B	0.05%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	4,191	$8K	$2.36B	0.25%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	1,632	$4K	$803.1M	0.23%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	47	$111	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,687	$4K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	8	$19	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	960,454	$1.7M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	5,051	$12K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	435	$1K	$1.29B	0.17%

About ALXO ETF Exposure

ALX Oncology Holdings Inc. (ALXO) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 106.6M, ALXO is a widely held institutional stock. The stock currently trades at $1.97. Investors can gain exposure to ALXO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALXO, sorted by portfolio weight.